-
IntroducedMar 10, 2022
-
Passed Senate
-
Passed House
-
Signed into Law
AN ACT CONCERNING THE ESSENTIAL WORKERS COVID-19 ASSISTANCE PROGRAM. To: (1) Expand coverage under the fund to essential workers falling in the 1c phase for the COVID-19 vaccination program, and (2) provide up to eighty hours of paid sick leave to all workers who were unable to work because they had to quarantine because of COVID-19.
Last Action See all actions
Senate • Apr 12, 2022: File Number 432 (LCO)
Latest Bill Text See all bill texts
Official Summary/Bill Text
Comments on SB 422
Tweets
Whip Lists
Sponsors
- Labor and Public Employees Committee
Votes
NO: 4
- Sampson R.
- Arora H.
- Anderson M.
- Rutigliano D.
OTHER: 0
Actions
- Apr 12, 2022 | Senate
- Reported Out of Legislative Commissioners' Office (LCO)
- Favorable Report, Tabled for the Calendar, Senate
- Senate Calendar Number 296
- File Number 432 (LCO)
- Apr 05, 2022 | Senate
- Referred to Office of Legislative Research and Office of Fiscal Analysis 04/11/22 5:00 PM (LCO)
- Mar 28, 2022 | Senate
- Filed with Legislative Commissioners' Office (LCO)
- Mar 24, 2022 | Senate
- Joint Favorable Substitute (LAB)
- Mar 11, 2022 | Senate
- Public Hearing 03/15
- Mar 10, 2022 | Senate
- Referred to Joint Committee on Labor and Public Employees
Bill Texts
- Raised BillPDF
- LAB Joint Favorable SubstitutePDF
- File No. 432PDF
- Committee Amendment LCO 3974 -- Labor and Public Employees CommitteePDF
- Uncalled Senate LCO Amendment #5321 (D)PDF
- Uncalled Senate LCO Amendment #5346 (D)PDF
- Uncalled Senate LCO Amendment #5769 (R)PDF
- Uncalled Senate LCO Amendment #5771 (R)PDF
- Uncalled Senate LCO Amendment #5822 (R)PDF
Documents
- Bill Analysis For File Copy 432
- Fiscal Note For File Copy 432
- Fiscal Note for Amendment LCO 5346 (See Fiscal Note Details)
- Fiscal Note for Amendment LCO 5321 (See Fiscal Note Details)
- Fiscal Note for Amendment LCO 5771 (See Fiscal Note Details)
- Fiscal Note for Amendment LCO 5822 (See Fiscal Note Details)
- Fiscal Note for Amendment LCO 5769 (See Fiscal Note Details)
- Committee Report LAB Joint Fav. Rpt
- Public Hearing Testimony